Table 1 Baseline characteristics of patients
Total population (n = 107) | Possible Epilepsy (n = 63, 58.9%) | Drug- resistant Epilepsy (n = 44, 41.1%) | |
|---|---|---|---|
Mean age, years (mean ± SD, range) | 56 ± 21 (18–88) | 52 ± 21 (18–88) | 62 ± 18 (29–88) |
Male gender, n (%) | 46 (43.0) | 28 (44.4) | 18 (40.9) |
Heart diseasesa, n (%) | 35 (32.7) | 13 (20.6) | 22 (50.0) |
Neurological diseasesb, n (%) | 32 (29.9) | 22 (34.9) | 10 (22.7) |
Cardiovascular drugsc, n (%) | 46 (43.0) | 21 (33.3) | 25 (56.8) |
Antiepileptic drugsd, n (%) | 77 (72.0) | 33 (52.4) | 44 (100.0) |
T-LOC/patient/year (mean ± SD, range) | 4 ± 4 (2–20) | 3 ± 4 (2–20) | 4 ± 4 (2–20) |
T-LOC Prodromal symptoms | 66 (61.7) | 40 (63.5) | 26 (59.1) |
After T-LOC characteristics | |||
Involuntary movements | 58 (54.2) | 37 (58.7) | 21 (47.7) |
Mental contusion, n (%) | 26 (24.3) | 26 (41.3) | 12 (27.3) |
Physical injury, n (%) | 55 (51.4) | 31 (49.2) | 24 (54.6) |
Comorbidities, n (%) | |||
Hypertension, n (%) | 41 (38.3) | 20 (31.7) | 21 (47.7) |
Diabetes, n (%) | 10 (9.3) | 6 (9.5) | 4 (9.1) |
Dyslipidemia, n (%) | 18 (16.8) | 9 (14.3) | 9 (20.5) |